THE WHAT? Beiersdorf has invested in digital dermatological appointment start-up dermanostic via its OSCAR&PAUL Beiersdorf Venture Capital unit.
THE DETAILS Dermanostic is in the digital health field and and offers app-based dermatological diagnosis.
The service can be booked around the clock for 25 euros irrespective of location, with the diagnoses then performed by experienced dermatologists within 24 hours once the patients have uploaded three photos and filled out a medical history questionnaire.
THE WHY? The investment is part of Eucerin’s digital strategy of creating new digital touchpoints and pioneering advisory services for consumers.
Ascan Voswinckel, Head of OSCAR&PAUL Beiersdorf Venture Capital, sees the investment and collaboration with dermanostic as an important step.
He said, “We believe digital health and teledermatology offer huge potential, especially among the younger target group. Digital dermatologist appointments offer our consumers significant added value as they allow for swift, straightforward, inexpensive, and professional advice regarding their skin indication. As such, dermanostic’s new digital service is the perfect fit for our Eucerin brand and innovatively complements our dermocosmetic brand’s digital consumer journey.”